Innovating and expanding diversity, equity, and inclusion in clinical trials, advancing industry solutions, and implementing technology
Innovating and expanding diversity, equity, and inclusion in clinical trials, advancing industry solutions, and implementing technology
The recent surge in development of equitable strategy throughout clinical research reflects the imperative drive to tackle the barriers facing global health equity. 85% of clinical trial participants are white, such a narrow patient pool lacks generalizability for medical solutions. This also hinders advancement of drugs targeting diseases such as multiple sclerosis, cancers and diabetes that disproportionately effect people of color.
Industry developments have produced successful equitable strategies that enable diverse research spaces however tackling institutionalized barriers is a complex issue. Join leading players within pharma and biotech along with clinical research organizations, advocacy groups, healthcare experts, decentralized platforms, and trial innovation services to further advance health equity through cross-industry action.
Step into interactive discussions and engaging presentations on the key challenges and opportunities presented today:
1. Building trust in communities - trust is something that is earned over time and the industry must develop on patient-centric approaches that provide long-term support and engage with communities on an even playing field. This event will emphasise solutions to build trust through constructing a network of community outreach partnerships, digital engagement platforms and approaches to change perceptions of clinical trials.
2. Advancing data systems - fluctuating global demographic patterns present a challenge to adapt equitable strategy and policy around the world. Building on data collection, processing and interpretation is the first step to advance focus and specify initiatives through technology and united expertise.
3. Globalizing health equity strategy - Following on from improved data capture enables unique health equity plans to be implemented globally, integrating digital solutions and communication platforms, accumulating foundation resources, and develop accurate site targeting.
4. Elevating decentralized trials - these digital platforms have enabled patient outreach to go beyond the physical possibilities, innovating and expanding these solutions through AI, advanced medtech and integrated support, enrolment and retention can advance equitable apporaches.
5. Facilitating trial access - developing networks to encompass all underrepresented groups through expanding long-term meaningful partnerships with healthcare organizations and advocacy groups, renovating treatment centers, and directly targeting institutionalized barriers to improve outreach.
Join us in February in Boston to help shape the conversation around diversity, equity and inclusion in clinical trials. Health Equity in Clinical Trials Congress 2023 (kisacoresearch.com)